Fig. 11From: An agent-based model of prostate Cancer bone metastasis progression and response to Radium223Model validation: (a) growth of 8 PC3 tumors (colored lines) in vivo over time and mean temporal trend with standard deviation (black bold). (b) in vivo data with standard deviation (black bold) are compared to in silico model output (i-th independent run – light grey; average trend – red bold)Back to article page